Toronto, October 31, 2022 – MEMOTEXT Corporation and Vanderbilt University Medical Center (VUMC) have successfully reached an agreement to make the Rapid Education And Communications for Health (REACH) text messaging
Amos Adler and Dr. Sean Kidd had an amazing opportunity to sit down with the BetaKit podcast to discuss digital therapeutics and where A4i fits in in the current healthcare
A4i is proud to announce the extension of the Help@Hand A4i pilot program with Riverside University Health System – Behavioral Health. The pilot program utilizes A4i to support clients, care
Mental health struggles are at an all-time high due to the impacts of COVID-19. Whether it was due to social isolation, financial burden, grief, or other factors, we continue to
Toronto March 2022, MEMOTEXT Corporation, Canada’s leading platform for the development, validation and commercialization of digital patient engagement communications announces a new collaboration with the University of Saskatchewan and the
Riverside Nov 4, 2021 – A4i Inc.announced today the launch of a new partnership with Riverside University Health System-Behavioral Health (RUHS –BH) and the Help@Hand program to expand the use
By: Dr. Sean Kidd and Amos Adler A4i Digital Therapeutic co-founders Amos Adler and Dr. Sean Kidd reflect on how their (mis)adventures in endurance sports are a metaphor for the
By: Gillian Drukmaler | Business Development Manager Over the past year and a half, you have no doubt heard that digital health is changing the way we think about health
By: Amos Adler M.Sc. LETS FACE IT, ITS BEEN A CHALLENGING YEAR March 11, was the one-year anniversary of the WHO declaring COVID-19 to be a global pandemic. Lockdowns, news
COVID-19 has changed life as we knew it, and likely for the foreseeable future. For companies that are working in office or on premise, one of the greatest concerns is maintaining staff
The start of a school year normally feels like the start of something exciting and new. New teachers. New faces. New friends. The promise of a new year ahead. This year is
In a recent study published in the Journal of Psychopharmacology, we were able to share the results of our SOFIA protocol used for children with Attention Deficit Hyperactivity Disorder (ADHD). SOFIA was created for children with ADHD to deliver reminders and
We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.
Get updates on new products, projects and stay on top of all things MEMOTEXT.